SARAH HUNSICKER: Open Payments
NPI 1578937108 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 46 payments from 17 companies in 2025. Trend: 2023 $918 · 2024 $959 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $183 |
| Novo Nordisk Inc | 10 | $143 |
| PFIZER INC. | 5 | $97 |
| Amgen Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
Products named: QULIPTA, Wegovy, OTEZLA, MOUNJARO, Ozempic, UBRELVY, VRAYLAR, ELIQUIS.
Industry payments across TX — which companies pay providers there.
